Show simple item record

dc.contributor.authorDe Oliveira Melo, Nathalia Caroline
dc.contributor.authorCuevas Sierra, Amanda
dc.contributor.authorArellano García, Laura
dc.contributor.authorPortillo Baquedano, María Puy ORCID
dc.contributor.authorMilton Laskibar, Iñaki
dc.contributor.authorMartínez, J. Alfredo
dc.date.accessioned2024-05-30T15:09:09Z
dc.date.available2024-05-30T15:09:09Z
dc.date.issued2023-10
dc.identifier.citationJournal of Functional Foods 109 : (2023) // Article ID 105808es_ES
dc.identifier.issn1756-4646
dc.identifier.issn2214-9414
dc.identifier.urihttp://hdl.handle.net/10810/68286
dc.description.abstractHigh-fat High-fructose diets have been associated with metabolic disorders and gut microbiota dysbiosis. Thus, the administration of probiotic or postbiotic from the strain Lacticaseibacillus rhamnosus GG has been investigated as a protective strategy. The aim of this study was to analyze the impact of L. rhamnosus GG administration in rodents fed a high-fat high-fructose diet. Male Wistar rats with oral supplementation of L. rhamnosus GG, viable or heat-inactivated, for 6 weeks were evaluated for somatic measurements, food and energy intake, biochemical markers, and gut microbiota. The daily administration of L. rhamnosus GG, as probiotic or postbiotic, was beneficial in attenuating weight gain, visceral fat deposition and visceral hypertriglyceridemic phenotype. Furthermore, the administration of heat-inactivated L. rhamnosus GG elicited an increase of species such as Akkermansia muciniphila, Blautia glucerasea, Sarcina maxima and L. rhamnosus, where the interaction between L. rhamnosus and Blautia glucerasea attenuated metabolic markers altered by the obesogenic diet.es_ES
dc.description.sponsorshipThis work was supported by Instituto de Salud Carlos III (CIBERobn) under Grant CB12/03/30007), the Basque Government under Grant IT1482-22 and Synergic R&D Projects in New and Emerging Scientific Areas on the Frontier of Science and Interdisciplinary Nature of The Community of Madrid (METAINFLAMATIONY2020/BIO-6600). Laura Isabel Arellano-García is a recipient of a doctoral fellowship from the Basque Government. Amanda Cuevas-Sierra is a recipient of a postdoctoral grant Sara Borrell from Instituto Carlos III.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectAkkermansia muciniphilaes_ES
dc.subjectBlautia gluceraseaes_ES
dc.subjecthigh fructose intakees_ES
dc.subjectLacticaseibacillus rhamnosuses_ES
dc.subjectpostbiotices_ES
dc.subjectprobiotices_ES
dc.titleOral administration of viable or heat-inactivated Lacticaseibacillus rhamnosus GG influences on metabolic outcomes and gut microbiota in rodents fed a high-fat high-fructose dietes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/).es_ES
dc.rights.holderAtribución-NoComercial-SinDerivadas 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S1756464623004085es_ES
dc.identifier.doi10.1016/j.jff.2023.105808
dc.departamentoesFarmacia y ciencias de los alimentoses_ES
dc.departamentoeuFarmazia eta elikagaien zientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Except where otherwise noted, this item's license is described as © 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/).